October 20, 2015 · FLEMING | NOLEN | JEZ, L.L.P.
In a recent study documented in the British Medical Journal, it was found that of the women who received an Essure implant, 2.4% of them needed to have follow-up surgeries within one year. This is in contrast to the 0.2% of women who had undergone sterilization in a laparoscopic manner that was minimally invasive. This increase indicates that out of every 1,000 women, 21 will require additional procedures. The leader of the study, Dr. Art Sedrakyan, stated, “small risk in large numbers of patients translates into large numbers.” If these findings were extrapolated to the entire United States, it would mean roughly 150,000 Essure patients would need a follow-up surgery according to Dr. Sedrakyan. Sometimes these can be major operations, including the possibility for hysterectomies.
According to Bayer, there are roughly 750,000 women throughout the world using the Essure contraceptive device. Around 70% of these women are in the United States. The Essure contraceptive device has been at the center of numerous lawsuits by patients claiming that the nickel-titanium coils have caused pain, perforation of the uterine walls and / or fallopian tubes, and allergic reactions.
The device was approved in 2002 and acquired by Bayer in 2013. More recently, it has faced multiple complaints from patients and many are calling for its removal from the market.
If you or someone you love was injured because of the Essure contraceptive, call Fleming | Nolen | Jez, L.L.P. to learn how we can help you.